Abstract:Insulin fibrillation provides a model for a broad class of amyloidogenic diseases. Conformational distortion of the native monomer leads to aggregation-coupled misfolding. Whereas beta-cells are protected from proteotoxicity by hexamer assembly, fibrillation limits the storage and use of insulin at elevated temperatures. Here, we have investigated conformational distortions of an engineered insulin monomer in relation to the structure of an insulin fibril. Anomalous (13)C NMR chemical shifts and rapid (15)N-detected (1)H-(2)H amide-proton exchange were observed in one of the three classical alpha-helices (residues A1-A8) of the hormone, suggesting a conformational equilibrium between locally folded and unfolded A-chain segments. Whereas hexamer assembly resolves these anomalies in accordance with its protective role, solid-state (13)C NMR studies suggest that the A-chain segment participates in a fibril-specific beta-sheet. Accordingly, we investigated whether helicogenic substitutions in the A1-A8 segment might delay fibrillation. Simultaneous substitution of three beta-branched residues (Ile(A2) --> Leu, Val(A3) --> Leu, and Thr(A8) --> His) yielded an analog with reduced thermodynamic stability but marked resistance to fibrillation. Whereas amide-proton exchange in the A1-A8 segment remained rapid, (13)Calpha chemical shifts exhibited a more helical pattern. This analog is essentially without activity, however, as Ile(A2) and Val(A3) define conserved receptor contacts. To obtain active analogs, substitutions were restricted to A8. These analogs exhibit high receptor-binding affinity; representative potency in a rodent model of diabetes mellitus was similar to wild-type insulin. Although (13)Calpha chemical shifts remain anomalous, significant protection from fibrillation is retained. Together, our studies define an "Achilles' heel" in a globular protein whose repair may enhance the stability of pharmaceutical formulations and broaden their therapeutic deployment in the developing world.

Insulin Amyloid Fibrillation Studied by Terahertz Spectroscopy and Other Biophysical Methods

Monitoring and Inhibition of Insulin Fibrillation by a Small Organic Fluorogen with Aggregation-Induced Emission Characteristics.

High resolution spectroscopy reveals fibrillation inhibition pathways of insulin

Photo-induced Inhibition of Insulin Amyloid Fibrillation on Online Laser Measurement.

Study of Insulin Aggregation and Fibril Structure under Different Environmental Conditions

Early Events in Insulin Fibrillization Studied by Time-Lapse Atomic Force Microscopy

Structural characterization and cryo-electron tomography analysis of human islet amyloid polypeptide suggest a synchronous process of the hIAPP1−37 amyloid fibrillation

Mechanistic modeling of amyloid oligomer and protofibril formation in bovine insulin

Structure and Thermodynamics of Amylin Dimer Studied by Hamiltonian-Temperature Replica Exchange Molecular Dynamics Simulations

Cationic molecular probes based on aggregation-induced emission for fluorescent sensing and super-resolution imaging of insulin fibrosis

Atomic resolution structure of full-length human insulin fibrils

Lability landscape and protease resistance of human insulin amyloid: a new insight into its molecular properties

Conformational Distribution And Alpha-Helix To Beta-Sheet Transition Of Human Amylin Fragment Dimer

Effect of 33 Hz Pulsed Electric Field on Insulin Amyloidosis

Identification of a Novel Parallel Β‐strand Conformation Within Molecular Monolayer of Amyloid Peptide

Structural characterization of amyloid aggregates with spatially resolved infrared spectroscopy

Structural evolution of the conformational ensembles in peptide fibrillar aggregates

Molecular Dynamics Simulation Study on the Molecular Structures of the Amylin Fibril Models

On the Protein Fibrillation Pathway: Oligomer Intermediates Detection Using ATR-FTIR Spectroscopy

Molecular Insights into the Self-Assembly of a Full-Length Hiapp Trimer: Β-Protofibril Formed by Β-Hairpin Lateral or Longitudinal Association

An Achilles' Heel in an Amyloidogenic Protein and Its Repair: INSULIN FIBRILLATION AND THERAPEUTIC DESIGN